Unknown

Dataset Information

0

No Impact of Body Mass Index on Outcome in Stroke Patients Treated with IV Thrombolysis BMI and IV Thrombolysis Outcome.


ABSTRACT:

Background and purpose

The impact of excess body weight on prognosis after stroke is controversial. Many studies report higher survival rates in obese patients ("obesity paradox"). Recently, obesity has been linked to worse outcomes after intravenous (IV) thrombolysis, but the number and sample size of these studies were small. Here, we aimed to assess the relationship between body weight and stroke outcome after IV thrombolysis in a large cohort study.

Methods

In a prospective observational multicenter study, we analyzed baseline and outcome data of 896 ischemic stroke patients who underwent IV thrombolysis. Patients were categorized according to body mass index (BMI) as underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), obese (30-34.9 kg/m2) or severely obese (>35 kg/m2). Using uni- and multivariate modeling, we assessed the relationship of BMI with favorable outcome (defined as modified Rankin Scale 0 or 1) and mortality 3 months after stroke as well as the occurrence of symptomatic intracerebral hemorrhages (sICH). We also measured the incidence of patients that had an early neurological improvement of >40% on the National Institutes of Health Stroke Scale (NIHSS) after 24 hours.

Results

Among 896 patients, 321 were normal weight (35.8%), 22 underweight (2.5%), 378 overweight (42.2%), 123 obese (13.7%) and 52 severely obese (5.8%). Three-month mortality was comparable in obese vs. non-obese patients (8.1% vs. 8.3%) and did not differ significantly among different BMI groups. This was also true for favorable clinical outcome, risk of sICH and early neurological improvement on NIHSS at 24 hours. These results remained unchanged after adjusting for potential confounding factors in the multivariate analyses.

Conclusion

BMI was not related to clinical outcomes in stroke patients treated with IVT. Our data suggest that the current weight-adapted dosage scheme of IV alteplase is appropriate for different body weight groups, and challenge the existence of the obesity paradox after stroke.

SUBMITTER: Branscheidt M 

PROVIDER: S-EPMC5058473 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

No Impact of Body Mass Index on Outcome in Stroke Patients Treated with IV Thrombolysis BMI and IV Thrombolysis Outcome.

Branscheidt Meret M   Schneider Juliane J   Michel Patrik P   Eskioglou Elissavet E   Kaegi Georg G   Stark Robert R   Fischer Urs U   Jung Simon S   Arnold Marcel M   Wertli Maria M   Held Ulrike U   Wegener Susanne S   Luft Andreas A   Sarikaya Hakan H  

PloS one 20161011 10


<h4>Background and purpose</h4>The impact of excess body weight on prognosis after stroke is controversial. Many studies report higher survival rates in obese patients ("obesity paradox"). Recently, obesity has been linked to worse outcomes after intravenous (IV) thrombolysis, but the number and sample size of these studies were small. Here, we aimed to assess the relationship between body weight and stroke outcome after IV thrombolysis in a large cohort study.<h4>Methods</h4>In a prospective ob  ...[more]

Similar Datasets

| S-EPMC9633080 | biostudies-literature
| S-EPMC5451428 | biostudies-other
| S-EPMC7313367 | biostudies-literature
| S-EPMC10359662 | biostudies-literature
| S-EPMC5710582 | biostudies-literature
| S-EPMC5874062 | biostudies-literature
| S-EPMC9683651 | biostudies-literature
| S-EPMC4330057 | biostudies-literature
| S-EPMC7612209 | biostudies-literature
| S-EPMC5559788 | biostudies-other